KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $224,785 | +23.2% | 12,941 | -0.1% | 0.00% | – |
| Q2 2023 | $182,392 | +36.6% | 12,954 | +4.4% | 0.00% | – |
| Q1 2023 | $133,553 | -28.2% | 12,412 | 0.0% | 0.00% | – |
| Q4 2022 | $185,932 | +6.8% | 12,412 | -8.5% | 0.00% | – |
| Q3 2022 | $174,162 | +29.2% | 13,564 | -2.5% | 0.00% | – |
| Q2 2022 | $134,788 | -3.1% | 13,910 | -0.6% | 0.00% | – |
| Q1 2022 | $139,140 | -30.1% | 13,998 | -17.3% | 0.00% | – |
| Q4 2021 | $199,000 | -1.5% | 16,931 | -4.5% | 0.00% | – |
| Q3 2021 | $202,000 | -22.0% | 17,725 | -4.8% | 0.00% | – |
| Q2 2021 | $259,000 | -17.8% | 18,623 | +9.4% | 0.00% | – |
| Q1 2021 | $315,000 | +5.0% | 17,016 | +0.4% | 0.00% | – |
| Q4 2020 | $300,000 | +25.5% | 16,950 | +8.5% | 0.00% | – |
| Q3 2020 | $239,000 | -24.6% | 15,621 | +27.9% | 0.00% | – |
| Q2 2020 | $317,000 | +103.2% | 12,209 | +21.0% | 0.00% | – |
| Q1 2020 | $156,000 | +69.6% | 10,088 | -4.1% | 0.00% | – |
| Q3 2019 | $92,000 | -34.8% | 10,514 | +1.3% | 0.00% | – |
| Q2 2019 | $141,000 | – | 10,381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
| GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
| Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
| HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
| Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
| Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
| Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
| Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
| Birchview Capital, LP | 30,000 | $353,000 | 0.23% |